HR 4629
Star Rating for Biosimilars Act
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Star Rating for Biosimilars Act, directs the Centers for Medicare & Medicaid Services (CMS) to incorporate measures into the Medicare Advantage program’s 5-star rating system to encourage the use of biosimilar medications. Specifically, CMS will assess how well Medicare Advantage plans provide access to these biosimilars, considering factors like formulary coverage, cost-sharing, and utilization management practices. The bill also extends these requirements to prescription drug plans under Part D of Medicare.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Bob Gibbs
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.